QIM
AVEO

Quantitative Investment Management’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Quantitative Investment Management’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-10,370
Closed -$165K – 901
2018
Q4 		$165K Buy
+10,370
New +$228K 0.01% 505
2018
Q3 		– Sell
-5,380
Closed -$121K – 978
2018
Q2 		$121K Buy
+5,380
New +$128K ﹤0.01% 696

Other funds holding AVEO

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
EWM
Evercore Wealth Management New York $6.36B AUM 20.35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Quantitative Investment Management's AVEO Position: Q1 2019 in Review

Quantitative Investment Management sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2019, closing a stake of 10,370 shares — an estimated $165K sold.

Quantitative Investment Management first reported a position in AVEO in Q2 2018 and held it in 2 quarters. The position peaked at $165K in Q4 2018. 83 funds tracked by Wall St. Rank hold AVEO as of Q1 2019.

  • Quantitative Investment Management reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2019 after selling out during the quarter.
  • Quantitative Investment Management sold 10,370 AVEO Pharmaceuticals, Inc. shares in Q1 2019, an estimated $165K.
  • Quantitative Investment Management first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2018 and held it in 2 quarters.
  • Quantitative Investment Management's AVEO Pharmaceuticals, Inc. position peaked at $165K in Q4 2018.
  • 83 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2019.

Based on Quantitative Investment Management's 13F filing for Q1 2019, filed 15 May 2019.